AYSE MINDIKOGLU to Creatinine
This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Creatinine.
Connection Strength
1.133
-
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
Score: 0.382
-
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
Score: 0.129
-
Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and?Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2.
Score: 0.108
-
Renal dysfunction in cirrhosis. Curr Opin Gastroenterol. 2015 May; 31(3):215-23.
Score: 0.107
-
A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014; 39(6):543-52.
Score: 0.100
-
Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013; 38(4):345-54.
Score: 0.096
-
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
Score: 0.085
-
Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57.
Score: 0.078
-
Evaluation of novel candidate filtration markers from a global metabolomic discovery for glomerular filtration rate estimation. Kidney Int. 2024 Mar; 105(3):582-592.
Score: 0.048